Dr. Barocas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-322-3000Fax+1 615-936-6095
Summary
- Dr. Daniel Barocas is a urologist in Nashville, TN and is affiliated with multiple hospitals in the area, including Vanderbilt University Medical Center and Tennessee Valley Healthcare System. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 16 years. He specializes in diagnosis and treatment of urologic cancers, including prostate, bladder and kidney cancer. He has expertise in minimally invasive surgery and open surgery and has access to cutting edge technologies such as image-guided prostate biopsies, new biomarkers and specialized PET scans. Dr. Barocas is an experienced health services researcher with funding from the NIH and other sources.
Education & Training
- Vanderbilt UniversityMPH, 2009 - 2010
- Vanderbilt University Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2007 - 2009
- NYP Hosp-Weill Cornell Med Ctr2002 - 2007
- New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2001 - 2003
- New York Presbyterian Hospital (Cornell Campus)Internship, Surgery, 2001 - 2002
- Johns Hopkins University School of MedicineClass of 2001
Certifications & Licensure
- TN State Medical License 2007 - 2026
- KY State Medical License 2022 - 2025
- AL State Medical License 2020 - 2024
- FL State Medical License 2020 - 2022
- GA State Medical License 2009 - 2019
- American Board of Urology Urology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial Start of enrollment: 2011 Jul 01
- Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer Start of enrollment: 2014 Mar 01
Publications & Presentations
PubMed
- 93 citationsProstate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.Edward M Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Daniel Barocas
Journal of the National Comprehensive Cancer Network. 2023-10-01 - 61 citationsEarly Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening.John T Wei, Daniel Barocas, Sigrid Carlsson, Fergus Coakley, Scott Eggener
The Journal of Urology. 2023-07-01 - 149 citationsAn open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasi...Vignesh T. Packiam, Donald L. Lamm, Daniel A. Barocas, Andrew Trainer, Benjamin Fand
Urologic Oncology. 2017-07-26
Press Mentions
- More U.S. Prostate Cancer Patients Choosing Active SurveillanceApril 3rd, 2023
- Seeking ‘No Regrets’ for More Prostate Cancer PatientsAugust 18th, 2022
- Advanced Prostate Cancer Cases Continue to Rise in U.S.May 21st, 2020
- Join now to see all
Professional Memberships
- Member
- Society of Urologic OncologyMember
- Southeastern Section of the American Urological AssociationMember
- Young Urologic OncologistsExecutive Committee
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: